Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Reinstates ColgatePalmolive with Buy Rating and 93 Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
GD stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Goldman Sachs analyst Jason English has reinstated Colgate-Palmolive (NYSE: CL) with a Buy rating and a price target of $93, signaling optimism about the company’s future performance and stock value. This decision underscores Goldman Sachs’ confidence in Colgate-Palmolive’s outlook and financial well-being.

The reinstatement by Goldman Sachs is in line with Colgate-Palmolive’s recent financial activities, including adjustments to goodwill values in SEC filings. These adjustments are standard practices to ensure accurate financial reporting and valuation.

Additionally, Goldman Sachs’ decision to reinstate Colgate-Palmolive reflects a strategic move based on the company’s market performance and conditions. It serves as a recommendation to investors to consider purchasing Colgate-Palmolive stock at its current price, with the potential for it to reach $93 per share according to the price target set by Goldman Sachs.

Overall, Goldman Sachs’ reinstatement of Colgate-Palmolive with a Buy rating and $93 price target signifies a positive evaluation of the company’s growth prospects and financial stability, offering valuable guidance to investors interested in this stock.

Colgate-Palmolive Company (CL) Stock Price Drops Slightly on March 1, 2024: What Investors Need to Know

On March 1, 2024, Colgate-Palmolive Company (CL) experienced a slight decrease in its stock price. The price of CL shares decreased by $0.31 since the market last closed, representing a 0.35% drop. The stock closed at $86.52 on the previous trading day. In pre-market trading on March 1, the stock dropped an additional $0.32.

Colgate-Palmolive Company is a well-established consumer goods company with a strong track record of success. Investors should also consider factors such as market trends, industry news, and company announcements when evaluating the performance of a stock. It’s always recommended to conduct thorough research and consult with a financial advisor before making any investment decisions.

Overall, the slight drop in CL’s stock price on March 1 should be viewed in the context of the broader market and the company’s overall performance. It’s important for investors to stay informed and make decisions based on a comprehensive analysis of all available information.

CL Corporation Stock Price Rises on Strong Financial Results for March 1, 2024

CL Corporation had a strong performance on March 1, 2024, as its stock price showed positive movement following the release of its financial results. According to data from CNN Money, the company reported total revenue of $19.46 billion for the past year, with a quarterly revenue of $4.95 billion. Net income for CL Corporation was reported at $2.30 billion for the past year, with a quarterly net income of $718.00 million. Earnings per share (EPS) for the company were $2.77 for the past year, with a quarterly EPS of $0.87. Investors reacted positively to CL Corporation’s financial results, as the stock price showed an upward trend on March 1, 2024. The strong performance in total revenue, net income, and EPS indicates that the company is on a solid growth trajectory. Overall, CL Corporation’s stock performance on March 1, 2024, reflects the company’s strong financial performance and positive outlook for future growth. Investors can be optimistic about the company’s potential for continued success based on its solid financial results.

Tags: CL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financings on laptop

Unveiling the Latest Trends in Broad-Spectrum Commodity Pricing Intelligence

Finance_Assets (3)

Utz Brands Analyst Scoreboard Recent Ratings and Price Targets

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

Recommended

Stepan Stock

Stepan Shares Face Market Pressure Despite Solid Operational Performance

2 months ago
TSS Inc Stock

TSS Inc Shares Surge on Strong Financial Performance and Strategic Moves

1 month ago
Finances

Analysts Predict Future Trajectory of MongoDB Inc Stock Price

2 years ago
SNDR stock news

RBC Bearings Incorporated: Strong Financial Performance and Strategic Acquisition by State of New Jersey Common Pension Fund D

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Canaan Stock Surges on Triple Catalyst Boost

L3Harris Shares Show Strength Amid Mixed Signals

Cytokinetics Faces Critical FDA Decision and Financial Pressure

BAE Systems Shares Maintain Strong Trajectory Amid Major Defense Contracts

Why Going Private Was the Only Viable Path for Focus Financial

CrowdStrike Shares Surge as AI Security Demand Intensifies

Trending

At T Stock
Analysis

AT&T Stock: Institutional Confidence Defies Market Weakness

by Andreas Sommer
November 6, 2025
0

While AT&T shares continue to face significant downward pressure, a notable divergence is emerging between price action...

Adobe Stock

Adobe’s AI Promise Clashes With Stock Market Reality

November 6, 2025
Bristol-Myers Squibb Stock

Bristol-Myers Squibb Navigates Financial and Legal Challenges Amid Strong Performance

November 6, 2025
Canaan Stock

Canaan Stock Surges on Triple Catalyst Boost

November 6, 2025
L3Harris Stock

L3Harris Shares Show Strength Amid Mixed Signals

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AT&T Stock: Institutional Confidence Defies Market Weakness
  • Adobe’s AI Promise Clashes With Stock Market Reality
  • Bristol-Myers Squibb Navigates Financial and Legal Challenges Amid Strong Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com